Search

In this paper, we establish a random epidemic model with double vaccination and spontaneous variation of the virus. Firstly, we prove the global existence and uniqueness of positive solutions for a stochastic epidemic model. Secondly, we prove the threshold R 0 * can be used to control the stochastic dynamics of the model. If R 0 * < 0 , the disease will be extinct with probability 1; whereas if R 0 * > 0 , the disease can almost certainly continue to exist, and there is a unique stable distribution. Finally, we give some numerical examples to verify our theoretical results. Most of the existing studies prove the stochastic dynamics of the model by constructing Lyapunov functions. However, the construction of a Lyapunov function of higher-order models is extremely complex, so this method is not applicable to all models. In this paper, we use the definition method suitable for more models to prove the stationary distribution. Most of the stochastic infectious disease models studied now are second-order or third-order, and cannot accurately describe infectious diseases. In order to solve this kind of problem, this paper adopts a higher price five-order model. [ABSTRACT FROM AUTHOR]

In this paper, a mathematical model based on COVID-19 is developed to study and manage disease outbreaks. The effect of vaccination with regard to its efficacy and percentage of population vaccinated in a closed population is investigated. To study virus transmission, the system employs six nonlinear ordinary differential equations with susceptible–exposed–asymptomatic–infected–vaccinated–recovered populations and the basic reproduction number are calculated. The proposed model describes for highly infectious diseases (such as COVID-19) in a closed containment area with no migration. This paper considers that the percentage of vaccinated population has a significant impact on the number of COVID-19 positive cases during the pandemic wave and examines how the pandemic rise time is delayed. Numerical simulation to investigate disease outbreaks when the community is undergoing vaccination is performed, taking the efficacy rate of the vaccine into account. Sensitivity Index values are calculated for the reproduction number and their relations with few other parameters are depicted. [ABSTRACT FROM AUTHOR]

Vaccination strategies remain one of the most effective and feasible preventive measures in combating infectious diseases, particularly during the COVID-19 pandemic. With the passage of time, continuous long-term lockdowns became impractical, and the effectiveness of contact-tracing procedures significantly declined as the number of cases increased. This paper presents a mathematical assessment of the dynamics and prevention of COVID-19, taking into account the constant and time-varying optimal COVID-19 vaccine with multiple doses. We attempt to develop a mathematical model by incorporating compartments with individuals receiving primary, secondary, and booster shots of the COVID-19 vaccine in a basic epidemic model. Initially, the model is rigorously studied in terms of qualitative analysis. The stability analysis and mathematical results are presented to demonstrate that the model is asymptotically stable both locally and globally at the COVID-19-free equilibrium state. We also investigate the impact of multiple vaccinations on the COVID-19 model's results, revealing that the infection risk can be reduced by administrating the booster vaccine dose to those individuals who already received their first vaccine doses. The existence of backward bifurcation phenomena is studied. A sensitivity analysis is carried out to determine the most sensitive parameter on the disease incidence. Furthermore, we developed a control model by introducing time-varying controls to suggest the optimal strategy for disease minimization. These controls are isolation, multiple vaccine efficacy, and reduction in the probability that different vaccine doses do not develop antibodies against the original virus. The existence and numerical solution to the COVID-19 control problem are presented. A detailed simulation is illustrated demonstrating the population-level impact of the constant and time-varying optimal controls on disease eradication. Using the novel concept of human awareness and several vaccination doses, the elimination of COVID-19 infections could be significantly enhanced. [ABSTRACT FROM AUTHOR]

This paper considers a stochastic susceptible exposed infectious recovered (SEIR) epidemic model with varying population size and vaccination. We aim to study the global dynamics of the reduced nonlinear stochastic proportional differential system. We first investigate the existence and uniqueness of global positive solution of the stochastic system. Then the sufficient conditions for the extinction and permanence in mean of the infectious disease are obtained. Furthermore, we prove that the solution of the stochastic system has a unique ergodic stationary distribution under appropriate conditions. Finally, the discussion and numerical simulation are given to demonstrate the obtained results. [ABSTRACT FROM AUTHOR]

In this paper, the author proposes a new SEIRS model that generalizes several classical deterministic epidemic models (e.g., SIR and SIS and SEIR and SEIRS) involving the relationships between the susceptible S, exposed E, infected I, and recovered R individuals for understanding the proliferation of infectious diseases. As a way to incorporate the most important features of the previous models under the assumption of homogeneous mixing (mass-action principle) of the individuals in the population N, the SEIRS model utilizes vital dynamics with unequal birth and death rates, vaccinations for newborns and non-newborns, and temporary immunity. In order to determine the equilibrium points, namely the disease-free and endemic equilibrium points, and study their local stability behaviors, the SEIRS model is rescaled with the total time-varying population and analyzed according to its epidemic condition R0 for two cases of no epidemic (R0 ≤ 1) and epidemic (R0 > 1) using the time-series and phase portraits of the susceptible s, exposed e, infected i, and recovered r individuals. Based on the experimental results using a set of arbitrarily-defined parameters for horizontal transmission of the infectious diseases, the proportional population of the SEIRS model consisted primarily of the recovered r (0.7-0.9) individuals and susceptible s (0.0-0.1) individuals (epidemic) and recovered r (0.9) individuals with only a small proportional population for the susceptible s (0.1) individuals (no epidemic). Overall, the initial conditions for the susceptible s, exposed e, infected i, and recovered r individuals reached the corresponding equilibrium point for local stability: no epidemic (DFE XDFE) and epidemic (EE XEE). [ABSTRACT FROM AUTHOR]

The spread of the COVID-19 pandemic has highlighted the close link between economics and health in the context of emergency management. A widespread vaccination campaign is considered the main tool to contain the economic consequences. This paper will focus, at the level of wealth distribution modeling, on the economic improvements induced by the vaccination campaign in terms of its effectiveness rate. The economic trend during the pandemic is evaluated, resorting to a mathematical model joining a classical compartmental model including vaccinated individuals with a kinetic model of wealth distribution based on binary wealth exchanges. The interplay between wealth exchanges and the progress of the infectious disease is realized by assuming, on the one hand, that individuals in different compartments act differently in the economic process and, on the other hand, that the epidemic affects risk in economic transactions. Using the mathematical tools of kinetic theory, it is possible to identify the equilibrium states of the system and the formation of inequalities due to the pandemic in the wealth distribution of the population. Numerical experiments highlight the importance of the vaccination campaign and its positive effects in reducing economic inequalities in the multi-agent society. [ABSTRACT FROM AUTHOR]

This paper analyses an SIRS epidemic model with the vaccination of susceptible individuals and treatment of infectious ones. Both actions are governed by a designed control system whose inputs are the subpopulations of the epidemic model. In addition, the vaccination of a proportion of newborns is considered. The control reproduction number R c of the controlled epidemic model is calculated, and its influence in the existence and stability of equilibrium points is studied. If such a number is smaller than a threshold value R ¯ c , then the model has a unique equilibrium point: the so-called disease-free equilibrium point at which there are not infectious individuals. Furthermore, such an equilibrium point is locally and globally asymptotically stable. On the contrary, if R c > R ¯ c , then the model has two equilibrium points: the referred disease-free one, which is unstable, and an endemic one at which there are infectious individuals. The proposed control strategy provides several free-design parameters that influence both values R c and R ¯ c . Then, such parameters can be appropriately adjusted for guaranteeing the non-existence of the endemic equilibrium point and, in this way, eradicating the persistence of the infectious disease. [ABSTRACT FROM AUTHOR]

Simple Summary: Intranasal vaccination is one of the methods used to stimulate mucosal immunity. It has been widely practised to control many human and animal respiratory diseases. Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which resulted in a global pandemic. COVID-19 has reminded some veterinarians of various contagious veterinary diseases, including coronavirus infections in animals. This article discusses the control of highly contagious diseases of veterinary importance with emphasis on an intranasal vaccination approach, and the potential of implementing similar strategies in human medicine to control the ongoing COVID-19 pandemic. The world is currently facing an ongoing coronavirus disease 2019 (COVID-19) pandemic. The disease is a highly contagious respiratory disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current control measures used by many countries include social distancing, wearing face masks, frequent hand washing, self-isolation, and vaccination. The current commercially available vaccines are injectable vaccines, although a few intranasal vaccines are in trial stages. The reported side effects of COVID-19 vaccines, perceptions towards the safety of the vaccines, and frequent mutation of the virus may lead to poor herd immunity. In veterinary medicine, attaining herd immunity is one of the main considerations in disease control, and herd immunity depends on the use of efficacious vaccines and the vaccination coverage in a population. Hence, many aerosol or intranasal vaccines have been developed to control veterinary respiratory diseases such as Newcastle disease, rinderpest, infectious bronchitis, and haemorrhagic septicaemia. Different vaccine technologies could be employed to improve vaccination coverage, including the usage of an intranasal live recombinant vaccine or live mutant vaccine. This paper discusses the potential use of intranasal vaccination strategies against human COVID-19, based on a veterinary intranasal vaccine strategy. [ABSTRACT FROM AUTHOR]